Exact Mass: 406.0446
Exact Mass Matches: 406.0446
Found 151 metabolites which its exact mass value is equals to given mass value 406.0446
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Lancerin
Lancerin is a C-glycosyl compound that is 9H-xanthen-9-one substituted by hydroxy groups at positions 1, 3, and 7 and a 1,5-anhydro-D-glucitol moiety at position 1. It has a role as a plant metabolite. It is a member of xanthones, a C-glycosyl compound and a polyphenol. Lancerin is a natural product found in Maclura cochinchinensis, Polygala tenuifolia, and other organisms with data available. A C-glycosyl compound that is 9H-xanthen-9-one substituted by hydroxy groups at positions 1, 3, and 7 and a 1,5-anhydro-D-glucitol moiety at position 1. Lancerin, isolated from the root bark of Cudraniu cochinchinensis, possesses anti-lipid peroxidation[1]. Lancerin, isolated from the root bark of Cudraniu cochinchinensis, possesses anti-lipid peroxidation[1].
7-Chloro-3,4',5,6,8-pentamethoxyflavone
7-Chloro-3,4,5,6,8-pentamethoxyflavone is found in citrus. 7-Chloro-3,4,5,6,8-pentamethoxyflavone is a constituent of a Citrus sp. (Dancy tangerine). Constituent of a Citrus species (Dancy tangerine). 7-Chloro-3,4,5,6,8-pentamethoxyflavone is found in citrus.
1-O-p-Coumaroyl-(b-D-glucose 6-O-sulfate)
1-O-p-Coumaroyl-(b-D-glucose 6-O-sulfate) is found in green vegetables. 1-O-p-Coumaroyl-(b-D-glucose 6-O-sulfate) is isolated from Pteridium aquilinum (bracken fern).
Carbonyloxycamptothecin
Glucoiberverin
Neolancerin
Neolancerin is a natural product found in Hypericum sampsonii and Gentiana thunbergii with data available. Neolancerin is a natural product with weak cytotoxic activity against HL-60 cells[1].
spongotine A
A member of the class of imidazolines that is 4,5-dihydro-1H-imidazole which is substituted by a 1H-indole-3-carbonyl group at position 2 and a 6-bromo-1H-indol-3-yl group at position 4S. It is a bisindole alkaloid isolated from the marine sponge, Spongosorites sp.
2-(Benzothiazol-2-ylsulfanyl)-1-phenothiazin-10-yl-ethanone
O1-[3-(Trifluoromethyl)benzoyl]-2-[4-(1,3,4-oxadiazol-2-yl)phenoxy]ethanehydroximamide
1-[3-(4-Chlorophenylaminocarbonyl)benzyl]-5-(trifluoromethyl)-2-pyridone
Acetyl-2,3,4,6-tetra-O-acetyl-5-thio-d-glucopyranoside
2,9-Dibenzyl-1,8-dioxa-2,9-diaza-dispiro[3.2.3.2]dodeca-5,11-dien-3,10-dithion|2,9-dibenzyl-1,8-dioxa-2,9-diaza-dispiro[3.2.3.2]dodeca-5,11-diene-3,10-dithione
4-chloro-5-O-methyl-3,4-deoxypsorospermin-3,5-diol
1,5-dihydroxyxanthone-6-O-beta-D-glucoside|1,5-Dihydroxyxanthone-6-O-??-D-glucoside
erigeroflavanone|methyl 2-[rel-(2R,3R)-3,4-dihydro-3,5,7-trihydroxy-2-(3,4-dihydroxyphenyl)-2-methoxy-4-oxo-2H-chromen-3-yl]acetate|rel-(2R,3R)-3,5,7,3,4-pentahydroxy-2-methoxy-flavanone-3-acetic acid methyl ester
2-(4-Hydroxyphenyl)-5,7-dihydroxy-6-[2-hydroxy-5-(hydroxycarbonyl)phenyl]-4H-1-benzopyran-4-one
4-O-beta-D-glucopyranosyl-1,7-dihydroxyxanthone|tenuiside A
3-(1H-Indole-3-yl)-6-(6-bromo-1H-indole-3-yl)-1,2,5,6-tetrahydropyrazine-2-one
3-(6-Bromo-1H-indole-3-yl)-6-(1H-indole-3-yl)-1,2,5,6-tetrahydropyrazine-2-one
1,7-dihydroxyxanthone-3-O-beta-D-glucopyranoside|xanthohypericoside
7-Chloro-3,4',5,6,8-pentamethoxyflavone
1-O-p-Coumaroyl-(b-D-glucose 6-O-sulfate)
N-(5-Chloro-2-pyridinyl)-2-[(4-cyanobenzoyl)amino]-5-methoxybenzamide
2-(4-(8-BROMO-2-OXO-2,3-DIHYDRO-1H-IMIDAZO[4,5-C]QUINOLIN-1-YL)PHENYL)-2-METHYLPROPANENITRILE
[(2R,3R,4S,5R,6R)-3,4,5-triacetyloxy-6-acetylsulfanyloxan-2-yl]methyl acetate
3,4-Bis(cyclopropylmethoxy)-N-(3,5-dichloropyridin-4-yl)benzamide
(2Z)-4-Oxo-4-[3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazine-7(8H)-yl]-1-(2,4,5-trifluorophenyl)butan-2-one
Piperazine-N,N-bis(2-hydroxypropanesulphonic acid) disodium salt
((3,5-DICHLORO-4-(3-ISOPROPYL-4-METHOXYPHENOXY)PHENYL)ETHYNYL)TRIMETHYLSILANE
1,1,1,2,2,3,3,4,4,5,5,6,6-Tridecafluoro-8-(propoxy)octane
Remoxipride hydrochloride
(S)-Remoxipride ((-)-Remoxipride) hydrochloride is a selective dopamine D2-receptor antagonist with an IC50 value of 1.57 μM. (S)-Remoxipride hydrochloride can be used for the research of psychotic disorder[1].
Fosphenytoin sodium
C78272 - Agent Affecting Nervous System > C264 - Anticonvulsant Agent D002491 - Central Nervous System Agents > D000927 - Anticonvulsants D002317 - Cardiovascular Agents > D026941 - Sodium Channel Blockers D049990 - Membrane Transport Modulators
9,10-Anthracenedione,1-amino-2-bromo-4-[(4-methylphenyl)amino]-
Disodium 3,3-(2-butyne-1,4-diylbis(oxy))bis(2-hydroxypropanesulphonate)
CPPHA
CPPHA is potent and selective positive allosteric modulator (PAM) of the mGluR5 and mGluR1 (metabotropic glutamate receptor). CPPHA can potentiate responses of mGluR5 and mGluR1 to activation of these receptors. CPPHA is developed for the research of central nervous system disorders[1][2].
cis-2-(2,4-dichlorophenyl)-2-(1h-imidazole-1-yl)methyl-4-(methane sulfonyloxy)methyl-1,3-dioxalane
2-(4-((2-(3-Chlorophenyl)-6-(trifluoromethyl)pyrimidin-4-yl)amino)phenyl)acetamide
(2E)-3-{3-[(5-Ethyl-3-iodo-6-methyl-2-oxo-1,2-dihydropyridin-4-YL)oxy]phenyl}acrylonitrile
Zimeldine hydrochloride
D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D017367 - Selective Serotonin Reuptake Inhibitors C78272 - Agent Affecting Nervous System > C94725 - Selective Serotonin Reuptake Inhibitor D018377 - Neurotransmitter Agents > D014179 - Neurotransmitter Uptake Inhibitors C78272 - Agent Affecting Nervous System > C265 - Antidepressant Agent D049990 - Membrane Transport Modulators
3-Ethyl-3,6,6-trihydroxy-5-oxa-9,19-diazahexacyclo[15.4.1.02,7.09,21.011,20.013,18]docosa-1(21),2(7),11(20),12,14,16,18-heptaene-4,8,22-trione
3-Thiophenecarboxylic acid 4-[[5-(1-naphthalenyl)-1,3,4-oxadiazol-2-yl]thio]but-2-ynyl ester
2-[(3-Cyano-4-thiophen-2-yl-5,6,7,8-tetrahydroquinolin-2-yl)thio]-2-phenylacetic acid
6-[(2,4-Dichlorophenoxy)methyl]-3-(2-methoxyphenyl)-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazole
2-[(5Z)-5-(1-methyl-2-oxoindol-3-ylidene)-4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl]pentanedioic acid
N-[2-methoxy-5-(2-oxo-1-benzopyran-3-yl)phenyl]-5-nitro-2-furancarboxamide
N-(3-chlorophenyl)-2-[[2-(4-chlorophenyl)-6-oxo-1H-1,3,5-triazin-4-yl]thio]acetamide
2-Chloro-5-[[1-oxo-2-[(5-pyridin-4-yl-1,3,4-thiadiazol-2-yl)thio]ethyl]amino]benzoic acid
N-[(5-bromo-2-methoxyphenyl)methyl]-4-methyl-2,3-dihydro-1,4-benzothiazine-6-carboxamide
4-Nitrobenzoic acid [3-(2,6-dichlorophenyl)-5-methyl-4-isoxazolyl]methyl ester
N-[(E)-[5-(3-chloro-4-methylphenyl)furan-2-yl]methylideneamino]-2-[(5-methyl-1,3,4-thiadiazol-2-yl)sulfanyl]acetamide
(2S)-2-[(4S,5S)-8-bromo-4-methyl-5-(methylaminomethyl)-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol
(2R)-2-[(4R,5S)-8-bromo-4-methyl-5-(methylaminomethyl)-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol
(2S)-2-[(4R,5R)-8-bromo-4-methyl-5-(methylaminomethyl)-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol
(2S)-2-[(4S,5R)-8-bromo-4-methyl-5-(methylaminomethyl)-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol
(2R)-2-[(4R,5R)-8-bromo-4-methyl-5-(methylaminomethyl)-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol
(2R)-2-[(4S,5R)-8-bromo-4-methyl-5-(methylaminomethyl)-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol
(2S)-2-[(4R,5S)-8-bromo-4-methyl-5-(methylaminomethyl)-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol
2-Thiophenecarboxylic acid 4-[[5-(2-naphthalenyl)-1,3,4-oxadiazol-2-yl]thio]but-2-ynyl ester
(2R)-2-[(4S,5S)-8-bromo-4-methyl-5-(methylaminomethyl)-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol
2-[(E)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoyl]oxy-3-sulooxybutanedioic acid
[2-Hydroxy-5-[3-(4-methoxy-1-benzouran-5-yl)-3-oxopropanoyl]phenyl] hydrogen sulate
2-[3-[[(2R)-2-hydroxy-3,3-dimethyl-4-phosphonooxybutanoyl]amino]propanoylamino]ethanesulfonic acid
glucoiberverin(1-)
A thia-alkylglucosinolate resulting from the removal of the proton of the hydrogen sulfate group of glucoiberverin.
5,5',6,6',7,7'-hexahydroxy-3-methoxy-4,8'-dimethyl-1'h,3h-spiro[2-benzofuran-1,3'-[2]benzopyran]-4'-one
(5r)-3-(6-bromo-1h-indol-3-yl)-5-(1h-indol-3-yl)-5,6-dihydro-1h-pyrazin-2-one
methyl 13-chloro-15-formyl-6,14-dihydroxy-4,7,12-trimethyl-10-oxo-2,9-dioxatricyclo[9.4.0.0³,⁸]pentadeca-1(15),3(8),4,6,11,13-hexaene-5-carboxylate
2-chloro-1,3,6,8-tetrahydroxy-7-[(1s)-1-hydroxyhexyl]anthracene-9,10-dione
2-chloro-1,3,6,8-tetrahydroxy-7-(1-hydroxyhexyl)anthracene-9,10-dione
2-(4,5-dihydroxy-2-methoxyphenyl)-5,7-dihydroxy-3,6,8-trimethoxychromen-4-one
2-(2,4-dihydroxy-5-methoxyphenyl)-5,7-dihydroxy-3,6,8-trimethoxychromen-4-one
3-[2-(6-bromo-1h-indole-3-carbonyl)-4,5-dihydro-1h-imidazol-4-yl]-1h-indole
1,5-dihydroxyxanthone-6-o-β-d-glucoside
{"Ingredient_id": "HBIN001662","Ingredient_name": "1,5-dihydroxyxanthone-6-o-\u03b2-d-glucoside","Alias": "1,5-dihydroxy-6-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyxanthen-9-one; 1,5-dihydroxyxanthone-6-o-beta-d-glucoside; 1,5-Dihydroxy-6-(beta-D-glucopyranosyloxy)xanthone; AC1NSUSA","Ingredient_formula": "C19H18O10","Ingredient_Smile": "C1=CC(=C2C(=C1)OC3=C(C2=O)C=CC(=C3O)OC4C(C(C(C(O4)CO)O)O)O)O","Ingredient_weight": "406.3 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "SMIT15140;SMIT18990","TCMID_id": "25863;6183","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "5316845","DrugBank_id": "NA"}
1-o-p-coumaroylglucose; beta-d-form,6-o-sulfate
{"Ingredient_id": "HBIN002930","Ingredient_name": "1-o-p-coumaroylglucose; beta-d-form,6-o-sulfate","Alias": "NA","Ingredient_formula": "C15H18O11S","Ingredient_Smile": "NA","Ingredient_weight": "0","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "NA","TCMSP_id": "NA","TCM_ID_id": "9122","PubChem_id": "NA","DrugBank_id": "NA"}